4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Suzuken Co., Ltd. (9987) operates in the Medical Distribution industry and is headquartered in Nagoya, Japan with about 12,717 employees. Its market capitalization is roughly JPY 329 billion. In the fiscal year ended 2026-03-31, 9987 reported JPY 2.49T in revenue and JPY 38.1B in net income.
Suzuken Co., Ltd., together with its subsidiaries, primarily engages in the distribution of pharmaceuticals in Japan and internationally.
Interactive charts & full statements →
| Income statement | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|---|
| Total Revenue | JPY 2.49T | JPY 2.40T | JPY 2.39T | JPY 2.31T |
| Gross Profit | JPY 192.5B | JPY 192.2B | JPY 185.2B | JPY 179.7B |
| Operating Income (EBIT) | JPY 36.4B | JPY 37.1B | JPY 34.9B | JPY 32.6B |
| Net Income | JPY 38.1B | JPY 34.5B | JPY 29.0B | JPY 20.3B |
JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Dividends Paid | (JPY 7.1B) | (JPY 7.0B) | (JPY 6.3B) | (JPY 6.3B) | — |
JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Assets | JPY 1.16T | JPY 1.11T | JPY 1.23T | JPY 1.15T | — |
| Total Liabilities | JPY 739.8B | JPY 706.4B | JPY 812.3B | JPY 734.6B | — |
JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 9987 viewer.
This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी
About TickerBase · Data methodology & sources · Privacy · Terms